1. Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital Prague

2. Women in treatment in the Czech Republic System of data collection Data provider = TC centres Data collection provides Hygienic Service National sumary of data and data analysis provides Drug Epidemiology Headquarters of the Hygienic Station of the Capital Prague EMCDDA form is used monitoring of incidence of treated drug users (First Treatment Demand – FTD) since 1.1.1995 monitoring of prevalence of treated drug users and All Treatment Demand (ATD) since 1.1.2002

3. Women in treatment in the Czech Republic Age Sex District of T/C District of living Source of referral Current living status Employment status Highest education level Primary and secondary drugs Route of Administration Frequency of use Duration of regular use Risk behaviour: Curently or ever injected Shared past month or ever HIV and VH status Initial outcome Collected data:

4. Women in treatment in the Czech Republic - 2003 The age distribution of treated drug users according to sex Prevalence in the year 2003 Incidence (FTD) in the year 2003

5. Women in treatment in the Czech Republic - 2003 The age distribution of treated heroin and Pervitin users according to sex All Pervitin users in the Czech Republic in the year 2003 (Prevalence) All Pervitin users in Prague in the year 2003 (Prevalence)

6. Women in treatment in the Czech Republic 1995 – 2003 Trends of the number and of the share of first treated men and women

7. Women in treatment in the Czech Republic - 2003 The share of men and women according to groups of primary drug

8. Women in treatment in the Czech Republic – 2003 Groups of primary drug according to sex

9. Women in treatment in the Czech Republic, 1995 - 2003 Number of first treated women with drug use according to groups of primary drug

10. Women in treatment in the Czech Republic – 2003 Treated drug users according to the age

11. Women in treatment in the Czech Republic – 2003 Treated drug users according to the labour status and sex

12. Women in treatment in the Czech Republic - 2003 The number of women and the share of primary drugs according to age groups

13. Women in treatment in the Czech Republic, 1995 - 2003 First treated women with drug use according to age groups

14. Women in treatment in the Czech Republic – 2003 Groups of primary drug according to regions - Prevalence

15. Women in treatment in the Czech Republic – 2003 Groups of primary drug according to regions - FTD

16. Women in treatment in the Czech Republic – 2003 Average age of treated clients according to sex

17. Women in treatment in the Czech Republic – 2003 Route of administration of primary drug according to sex

18. Women in treatment in the Czech Republic – 2003 Primary and secondary drugs used by women FTD Prevalence

19. Women in treatment in the Czech Republic CONCLUSIONS: The highest number of treated women is in the age group 15 – 19 years The men : women ratio is lowest in both youngest age groups, in pervitin users in the Czech Republic is lower then 1 : 1 (in Prague in 3 youngest age groups) The trend of number of treated women is still increasing Treated women use pervitin more often then men Treated women are younger then men (55 % of all treated women are younger then 20 years) and they are more commonly in category pupil / student The share of pervitin use and heroin use among women grows with older age group; the share of cannabinoids use decreases The average age of treated women using heroin and opiates is about two years lower in comparison with men, in pervitin the difference is 3,5 years The share of treated women with inject administration of drug is about 4 % higher in comparison with men

20. Thanks for your attention!